Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,914 · 19 shown

Commercialized according to BDPM

ENHERTU 100 mg, powder for concentrate for infusion

Active ingredients: TRASTUZUMAB DÉRUXTÉCAN

Original BDPM details in French

Official name: ENHERTU 100 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB DÉRUXTÉCAN
Package description: 1 flacon(s) en verre jaune(brun) de 10 ml

CIS 63648081CIP7 5507929CIP13 3400955079293

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

HERCEPTIN 150 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: HERCEPTIN 150 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 15 ml

CIS 61276045CIP7 5621037CIP13 3400956210374

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

HERCEPTIN 600 mg, solution for injection in a vial

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: HERCEPTIN 600 mg, solution injectable en flacon
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 5 ml

CIS 62712079CIP7 5855769CIP13 3400958557699

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

HERZUMA 150 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: HERZUMA 150 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon en verre de 20 ml

CIS 62425937CIP7 5504950CIP13 3400955049500

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

HERZUMA 420 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: HERZUMA 420 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 50 ml

CIS 68153262CIP7 5505946CIP13 3400955059462

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Structural formula: Ado-trastuzumab emtansine

Commercialized according to BDPM

KADCYLA 100 mg, powder for concentrate for infusion

Active ingredients: Ado-trastuzumab emtansine

Original BDPM details in French

Official name: KADCYLA 100 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB EMTANSINE
Package description: 1 flacon(s) en verre de 15 ml

CIS 62170212CIP7 5857604CIP13 3400958576041

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

KADCYLA 160 mg, powder for concentrate for infusion

Active ingredients: Ado-trastuzumab emtansine

Original BDPM details in French

Official name: KADCYLA 160 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB EMTANSINE
Package description: 1 flacon(s) en verre de 20 ml

CIS 64565603CIP7 5857610CIP13 3400958576102

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

KANJINTI 150 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: KANJINTI 150 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 150 mg

CIS 61529324CIP7 5505435CIP13 3400955054351

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

KANJINTI 420 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: KANJINTI 420 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 420 mg

CIS 61193788CIP7 5505441CIP13 3400955054412

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPMANSM notice

OGIVRI 150 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: OGIVRI 150 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 15 ml

CIS 60990496CIP7 5506082CIP13 3400955060826

View details

Estimated priceAsk the manager for the priceSupply resumed

Commercialized according to BDPMANSM notice

OGIVRI 420 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: OGIVRI 420 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 50 ml

CIS 65643371CIP7 5506770CIP13 3400955067702

View details

Estimated priceAsk the manager for the priceSupply resumed

Commercialized according to BDPM

ONTRUZANT 150 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: ONTRUZANT 150 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon en verre de 150 mg de poudre

CIS 62787822CIP7 5505508CIP13 3400955055082

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ONTRUZANT 420 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: ONTRUZANT 420 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 420 mg de poudre

CIS 64346029CIP7 5506330CIP13 3400955063308

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

PHESGO 1200 mg/600 mg, solution for injection

Active ingredients: Pertuzumab, Trastuzumab

Original BDPM details in French

Official name: PHESGO 1200 mg/600 mg, solution injectable
Active ingredients: PERTUZUMAB, TRASTUZUMAB
Package description: 1 flacon(s) en verre de 15 ml

CIS 67178992CIP7 5507902CIP13 3400955079026

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

PHESGO 600 mg/600 mg, solution for injection

Active ingredients: Pertuzumab, Trastuzumab

Original BDPM details in French

Official name: PHESGO 600 mg/600 mg, solution injectable
Active ingredients: PERTUZUMAB, TRASTUZUMAB
Package description: 1 flacon(s) en verre de 10 ml

CIS 63806777CIP7 5507903CIP13 3400955079033

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TRAZIMERA 150 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: TRAZIMERA 150 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 15 ml

CIS 64461946CIP7 5505671CIP13 3400955056713

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TRAZIMERA 420 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: TRAZIMERA 420 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 30 ml

CIS 65913265CIP7 5506481CIP13 3400955064817

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ZERCEPAC 150 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: ZERCEPAC 150 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 20 ml

CIS 60924642CIP7 5507550CIP13 3400955075509

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ZERCEPAC 420 mg, powder for concentrate for infusion

Active ingredients: Trastuzumab

Original BDPM details in French

Official name: ZERCEPAC 420 mg, poudre pour solution à diluer pour perfusion
Active ingredients: TRASTUZUMAB
Package description: 1 flacon(s) en verre de 50 ml

CIS 69892199CIP7 5508336CIP13 3400955083368

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.